St. Jude's CardioMEMS Showing Results In HF
Executive Summary
Results from the CHAMPION study give St. Jude hope that its CardioMEMS system will stem the tide of heart failure.
You may also be interested in...
Medtechs At The Wheel In New Health Care Landscape
2016 was a year of surprise and change in political circles, but that's nothing new for the medtech industry, which over a number of years has become accustomed to health care systems demanding different and ever-higher levels of service. Smart medtechs have been ahead of the curve, but the whole industry now factors in clients' wider needs in a holistic approach to patient care. Many companies' current M&A policies are already reflecting the changes to come.
Value-Based Medtech Rides The Money-Go-Round Into 2016
The wider medtech industry saw only 2% growth in 2015, and medtechs in established markets face continued low growth for the next three to five years. The medtech M&A bonanza continued into 2015 and there is no end in sight in 2016 as manufacturers seek to augment and fine-tune portfolios to meet the new demands of payers and providers; longer term, there are signs of a change in the top global medtech rankings.
Value-Based Medtech Rides The Money-Go-Round Into 2016
The M&A bonanza for companies in the medtech sector continued into 2015 and there is no end in sight in 2016 as manufacturers seek to augment and fine-tune portfolios to meet the new demands of payers and providers. Longer term, there are signs of a change in the top global medtech rankings.